Decision-making on malaria vaccine introduction: the role of cost-effectiveness analyses.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

1. Endectocides as a complementary intervention in the malaria control program: a systematic review.Systematic reviews · 2021
   Pooled it
2. Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi.BMC public health · 2020
   Trial
3. Effect of immune regulatory pathways after immunization with GMZ2 malaria vaccine candidate in healthy lifelong malaria-exposed adults.Vaccine · 2020
   Trial
4. Insights from modelling malaria vaccines for policy decisions: the focus on RTS,S.Malaria journal · 2021
   Review
5. Case reduction and cost-effectiveness of the RTS,S/AS01 malaria vaccine alongside bed nets in Lilongwe, Malawi.Vaccine · 2020
   Article
6. Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon.Malaria journal · 2016
   Article
7. Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models.Lancet (London, England) · 2016
   Article
8. Costing RTS,S introduction in Burkina Faso, Ghana, Kenya, Senegal, Tanzania, and Uganda: A generalizable approach drawing on publicly available data.Vaccine · 2015
   Article
9. Paths to a malaria vaccine illuminated by parasite genomics.Trends in genetics : TIG · 2015
   Review
10. Modeling the public health impact of malaria vaccines for developers and policymakers.BMC infectious diseases · 2013
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as